Inhibition by dexamethasone of Langerhans cell migration: Influence of epidermal cytokine signals

Immunopharmacology

Volumn 41, Issue 3, 1999, Pages 235-243

  Cumberbatch, Marie ^a   Dearman, Rebecca J ^a   Kimber, Ian ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

Dendritic cells; Dexamethasone; Interleukin 1 ; Langerhans cells; Tumour necrosis factor

Indexed keywords

CYTOKINE; DEXAMETHASONE; GLUCOCORTICOID; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DRUG MECHANISM; EPIDERMIS; INTRAPERITONEAL DRUG ADMINISTRATION; LANGERHANS CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN INFLAMMATION; SKIN SENSITIZATION;

ANIMALS; CELL MOVEMENT; DENDRITIC CELLS; DEXAMETHASONE; INTERLEUKIN-1; LANGERHANS CELLS; MICE; MICE, INBRED BALB C; NF-KAPPA B; SKIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032980921     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(99)00037-5     Document Type: Article

References (33)

1. Ashworth J., Booker J., Breathnach S.M. Effects of topical corticosteroid therapy on Langerhans cell antigen presenting function in human skin. Br. J. Dermatol. 118:1988;457-470.
2. Auphan N., DiDonato J.A., Rosette C., Helmberg A., Karin M. Immunosuppression by glucocorticoids: inhibition of NF-KB activity through induction of IKBα synthesis. Science. 270:1995;286-290.
3. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature. 392:1998;245-252.
4. + lymphocytes. J. Immunol. 158:1997;5589-5595.
5. Burrows W.M., Stoughton R.B. Inhibition of induction of human contact sensitization by topical glucocorticosteroids. Arch. Dermatol. 112:1976;175-178.
6. Chainy G.B.M., Singh S., Raju U., Aggarwal B.B. Differential activation of the nuclear factor-KB by TNF muteins specific for the p60 and p80 TNF receptors. J. Immunol. 157:1996;2410-2417.
7. Cumberbatch M., Kimber I. Phenotypic characteristics of antigen-bearing cells in the draining lymph nodes of contact sensitized mice. Immunology. 71:1990;404-410.
8. Cumberbatch M., Kimber I. Dermal tumour necrosis factor-α induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans cell migration. Immunology. 75:1992;257-263.
9. Cumberbatch M., Kimber I. Tumour necrosis factor-α is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology. 84:1995;31-35.
10. Cumberbatch M., Fielding I., Kimber I. Modulation of epidermal Langerhans cell frequency by tumour necrosis factor-α Immunology. 81:1994;395-401.
11. Cumberbatch M., Dearman R.J., Kimber I. Interleukin 1β and the stimulation of Langerhans cell migration: comparisons with tumour necrosis factor α Arch. Dermatol. Res. 289:1997;277-284.
12. Cumberbatch M., Dearman R.J., Kimber I. Langerhans cells require signals from both tumour necrosis factor-α and interleukin-1β for migration. Immunology. 92:1997;388-395.
13. Enk A.H., Katz S.I. Early molecular events in the induction phase of contact sensitization. Proc. Natl. Acad. Sci. USA. 89:1992;1398-1402.
14. Enk A.H., Angeloni V.L., Udey M.C., Katz S.I. An essential role for Langerhans cell-derived IL-1β in the initiation of primary immune responses in skin. J. Immunol. 150:1993;3698-3704.
15. Fushimi T., Okayama H., Seki T., Shimura S., Shirato K. Dexamethasone suppressed gene expression and production of interleukin-10 by human peripheral blood mononuclear cells and monocytes. Int. Arch. Allergy Immunol. 112:1997;13-18.
16. Heufler C., Topar G., Koch F., Trockenbacher B., Kampgen E., Romani N., Schuler G. Cytokine gene expression in murine epidermal cell suspensions: interleukin 1β and macrophage inflammatory protein 1α are selectively expressed in Langerhans cells but are differentially regulated in culture. J. Exp. Med. 176:1992;1221-1226.
17. Holt P.G., Thomas J.A. Steroids inhibit uptake and/or processing but not presentation of antigen by airway dendritic cells. Immunology. 91:1997;145-150.
18. Kern J.A., Lamb R.J., Reed J.C., Daniele R.P., Nowell P.C. Dexamethasone inhibition of interleukin 1β production by human monocytes. Posttranscriptional mechanisms. J. Clin. Invest. 81:1988;237-244.
19. Kimber I., Cumberbatch M. Dendritic cells and cutaneous immune responses to chemical allergens. Toxicol. Appl. Pharmacol. 117:1992;137-146.
20. Knight S.C., Krejci J., Malkovsky M., Colizzi V., Gautam A., Asherson G.L. The role of dendritic cells in the initiation of immune responses to contact sensitizers: 1. In vivo exposure to antigen. Cell. Immunol. 94:1985;427-434.
21. Kripke M.L., Munn C.G., Jeevan A., Tang J.-M., Bucana C. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J. Immunol. 145:1990;2833-2838.
22. Kunicka J.E., Talle M.A., Denhardt G.H., Brown M., Prince L.-A., Goldstein G. Immunosuppression by glucocorticoids: inhibition of production of multiple lymphokines by in vivo administration of dexamethasone. Cell. Immunol. 149:1993;39-49.
23. Lappin M.B., Kimber I., Norval M. The role of dendritic cells in cutaneous immunity. Arch. Dermatol. Res. 288:1996;109-121.
24. Larregina A., Morelli A., Kolkowski E., Fainboim L. Flow cytometric analysis of cytokine receptors on human Langerhans cells. Changes observed after short-term culture. Immunology. 87:1996;317-325.
25. Lee S.W., Tsou A.-P., Chan H., Thomas J., Petrie K., Eugui E.M., Allison A.C. Glucocorticoids selectively inhibit the transcription of the interleukin 1β gene and decrease the stability of interleukin 1β mRNA. Proc. Natl. Acad. Sci. USA. 85:1988;1204-1208.
26. Macatonia S.E., Edwards A.J., Knight S.C. Dendritic cells and the initiation of contact sensitivity to fluorescein isothiocyanate. Immunology. 59:1986;509-514.
27. Macatonia S.E., Knight S.C., Edwards A.J., Griffiths S., Fryer P. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies. J. Exp. Med. 166:1987;1654-1667.
28. Nelson D.J., McWilliam A.S., Haining S., Holt P.G. Downmodulation of airway intraepithelial cell populations following local and systemic exposure to steroids. Am. J. Respir. Crit. Care Med. 151:1995;475-480.
29. Remick D.G., Strieter R.M., Lynch J.P. III, Nguyen D., Eskandari M., Kunkel S.L. In vivo dynamics of murine tumor necrosis factor-α gene expression. Kinetics of dexamethasone-induced suppression. Lab. Invest. 60:1989;766-771.
30. Ryffel B., Brockhaus M., Greiner B., Mihatsch M.J., Gudat F. Tumour necrosis factor receptor distribution in human lymphoid tissue. Immunology. 74:1991;446-452.
31. Scheinman R.I., Cogswell P.C., Lofquist A.K., Baldwin A.S. Jr. Role of transcriptional activation of IKBα in mediation of suppression by glucocorticoids. Science. 270:1995;283-286.
32. Waage A., Bakke O. Glucocorticoids suppress the production of tumour necrosis factor by lipopolysaccharide-stimulated human monocytes. Immunology. 63:1988;299-302.
33. Wang B., Kondo S., Shivji G.M., Fujisawa H., Mak T.W., Sauder D.N. Tumour necrosis factor receptor II (p75) signalling is required for the migration of Langerhans cells. Immunology. 88:1996;284-288.